Key statistics
As of last trade Applied Therapeutics Inc (2UV:DUS) traded at 6.89, -10.05% below its 52-week high of 7.66, set on Oct 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.91 |
---|---|
High | 6.91 |
Low | 6.89 |
Bid | 6.96 |
Offer | 7.17 |
Previous close | 7.08 |
Average volume | 371.13 |
---|---|
Shares outstanding | 114.85m |
Free float | 108.75m |
P/E (TTM) | -- |
Market cap | 884.32m USD |
EPS (TTM) | -1.52 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 08:30 BST.
More ▼
Announcements
- Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia
- Applied Therapeutics to Participate in Upcoming Investor Conferences
- Applied Therapeutics Reports Second Quarter 2024 Financial Results
- Applied Therapeutics Added to Russell 3000® Index
- Applied Therapeutics Reports First Quarter 2024 Financial Results
- Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference
- Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
- Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
- Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
- Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
More ▼